CN103584077A - 一种保健食品的组合物 - Google Patents
一种保健食品的组合物 Download PDFInfo
- Publication number
- CN103584077A CN103584077A CN201210287811.5A CN201210287811A CN103584077A CN 103584077 A CN103584077 A CN 103584077A CN 201210287811 A CN201210287811 A CN 201210287811A CN 103584077 A CN103584077 A CN 103584077A
- Authority
- CN
- China
- Prior art keywords
- parts
- health food
- taurine
- massecuite
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 235000013402 health food Nutrition 0.000 title claims abstract description 22
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 40
- 229960003080 taurine Drugs 0.000 claims abstract description 20
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 235000009103 Canarium album Nutrition 0.000 claims abstract description 17
- 244000012254 Canarium album Species 0.000 claims abstract description 17
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 17
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 14
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 10
- 239000010642 eucalyptus oil Substances 0.000 claims abstract description 10
- 229940044949 eucalyptus oil Drugs 0.000 claims abstract description 10
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940041616 menthol Drugs 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims description 18
- 244000197580 Poria cocos Species 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 150000002692 maltoses Chemical class 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 14
- 210000004185 liver Anatomy 0.000 abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- 238000010438 heat treatment Methods 0.000 abstract description 9
- 239000002674 ointment Substances 0.000 abstract description 8
- 239000005913 Maltodextrin Substances 0.000 abstract description 5
- 229940035034 maltodextrin Drugs 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 238000003756 stirring Methods 0.000 abstract description 4
- 235000000346 sugar Nutrition 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000010000 Hovenia dulcis Species 0.000 abstract 2
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 2
- 235000020429 malt syrup Nutrition 0.000 abstract 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000012856 packing Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 208000007848 Alcoholism Diseases 0.000 description 17
- 201000007930 alcohol dependence Diseases 0.000 description 16
- 235000019441 ethanol Nutrition 0.000 description 11
- 239000007937 lozenge Substances 0.000 description 7
- 230000001681 protective effect Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 240000007817 Olea europaea Species 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000005229 liver cell Anatomy 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- 241000723353 Chrysanthemum Species 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- -1 flavone compound Chemical class 0.000 description 3
- 231100000753 hepatic injury Toxicity 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010019837 Hepatocellular injury Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003035 anti-peroxidant effect Effects 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 231100000437 hepatocellular injury Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000007788 Acute Liver Failure Diseases 0.000 description 1
- 206010000804 Acute hepatic failure Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000202052 Poncirus trifoliata Species 0.000 description 1
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000836 acute liver failure Toxicity 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明一种保健食品的组合物，它是由以下原料和重量份数组成：枳椇子50-60份、葛根30-40份、青果20-30份、菊花20-30份、茯苓20-30份、橘皮10-15份、牛磺酸3-5份、白砂糖750份、麦芽糖饴260份、麦芽糊精20份、薄荷脑3-5份、桉叶油0.5份；取枳椇子、葛根、青果、菊花、茯苓、橘皮置提取锅中加水适量加热煮沸提取三次即得药汁，药汁浓缩成含水约40％得稠膏，加入牛磺酸混合均匀得药膏备用；然后将白砂糖、麦芽糖饴、麦芽糊精置熬糖锅中加适量水边加热边搅拌熬煮至温度达145℃，停止加热，加入药膏，抽真空至真空度达0.08MPa即得糖膏，将糖膏出锅置于冷却台上加入薄荷脑、桉叶油混合均匀即得混合糖膏，压片、包装即得产品。本发明配方合理，原料均为食品原料，无毒副作用，具有解酒防醉护肝的保健功能。
Description
技术领域
本发明涉及一种保健食品的组合物，具体是指一种用于解酒防醉护肝的含片保健食品。
技术背景
在日常生活中，酒是人们交际、宴请、喜庆等不可缺少的饮品，可使人兴奋精神、拉近距离、密切关系，但是饮酒或长期饮酒或过度饮酒会出现急性和慢性酒精中毒，严重损害身体健康，影响工作和生活，更甚者会危及社会安全。因而，解酒防醉的物品应需而生，本发明为了功效确切和避免解酒药品的毒副作用，采用对解酒作用明显的食品原料，经反复研究和试验科学配制而成，具有明显的解酒防醉护肝的功效，而且具有制造工艺简单、使用和携带方便等优点。
发明内容
本发明的目的是提供一种保健食品的组合物，特别是一种具有解酒防醉护肝的含片保健食品组合物。
本发明的目的是这样实现的，一种保健食品的组合物，具体是一种具有解酒防醉护肝的含片保健食品组合物，是由以下原料和重量份数组成：枳椇子50-60份、葛根30-40份、青果20-30份、菊花20-30份、茯苓20-30份、橘皮10-15份、牛磺酸3-5份、白砂糖750份、麦芽糖饴260份、麦芽糊精20份、薄荷脑3-5份、桉叶油0.5份；取枳椇子、葛根、青果、菊花、茯苓、橘皮置提取锅中加水适量加热煮沸提取三次即得药汁，药汁浓缩成含水约40％得稠膏，加入牛磺酸混合均匀得药膏备用；然后将白砂糖、麦芽糖饴、麦芽糊精置熬糖锅中加适量水边加热边搅拌熬煮至温度达145℃，停止加热，加入药膏，抽真空至真空度达0.08MPa即得糖膏，将糖膏出锅置于冷却台上加入薄荷脑、桉叶油混合均匀即得混合糖膏，压片、包装即得产品。
本发明制成的产品为含片型硬质糖果保健食品，由于主要功效原料枳椇子、葛根、青果、菊花、茯苓、橘皮、牛磺酸具有独特的功效，再经科学的配方，先进的生产工艺，使得其功效成分充分提取并保留，试验证明具有显著的解酒防醉护肝的保健功能，无毒副作用，适合于人们长期食用。
具体实施方式
本发明公开了一种保健食品的组合物，具体是一种具有解酒防醉护肝的含片保健食品组合物，是由以下原料和重量份数组成：枳椇子50-60份、葛根30-40份、青果20-30份、菊花20-30份、茯苓20-30份、橘皮10-15份、牛磺酸3-5份、白砂糖750份、麦芽糖饴260份、麦芽糊精20份、薄荷脑3-5份、桉叶油0.5份
本发明的较佳实施例中主要功效原料枳椇子、葛根、青果、菊花、茯苓、橘皮、牛磺酸进行阐述，以使本发明的优点和特征能更易于被本领域技术人员领会和理解，从而有利于对本发明的保护。
本发明一种保健食品的组合物所述的枳椇子，又名拐枣，为鼠李科植物枳椇的带有肉质果柄的果实或种子，性味甘酸平，主治酒醉、烦热、口渴、呕吐、二便不利。明代王肯堂的《政治准绳》记载：“解酒无如枳椇子之妙”，《滇南本草》载其“能解酒毒”。研究表明枳椇子果实含葡萄糖、苹果酸钙、生物碱类、槲皮素、黄酮类化合物以及脂肪酸类等成分。动物实验证实，枳椇子水提液能够拮抗酒精中毒所致小鼠肝脏脂质过氧化损伤，保护肝细胞免受自由基的毒害，延缓和防止乙醇所致的脂肪肝的形成，对急慢性酒精性肝损伤有明显的保护作用。医学研究表明，枳椇子能够加快酒精的代谢，降低其在血液中的浓度，枳椇子的水提液、甲醇提取物、乙酸乙酯提取物对CCl4诱导的肝细胞损伤均具有保护作用，但以水提物最强。
本发明一种保健食品的组合物所述的葛根，为豆科植物野葛或甘葛藤的干燥根，性味甘辛凉，具有解肌退热、生津、透疹、升阳止泻之功。《千金方》“治酒醉不醒”，《药性论》载其“主解酒毒”。其主要成分为黄酮类化合物，实验证明葛根总黄酮具有“解酒毒”作用，葛根能有效地拮抗酒精引起的肝组织脂质过氧化损害。研究用小白鼠饮用乙醇30d后，明显出现肝细胞点状或小叶状坏死，肝细胞水肿，颗粒变性等生理病变；但饮用乙醇同时加服葛根水提取液喂养30d后，酒精性肝炎的各项病理均有明显的好转，说明葛根能降低酒精性肝的损伤。
本发明一种保健食品的组合物所述的青果，又称橄榄，为橄榄科植物橄榄的干燥成熟果实，性味甘酸平，具有，清热、利咽、生津、解毒之功。《开宝本草》记载青果“生食煮饮并消酒毒”，《本草备要》载“橄榄，肺胃之果，清咽生津，除烦醒酒”。研究证明青果含蛋白质、脂肪、碳水化合物、钙、磷、铁、抗坏血酸、香树脂醇等多种成分。实验表明，从青果中提取出的物质对由半乳糖胺引起的鼠肝细胞中毒有保护作用。有研究者以橄榄、枳椇子为主组成的配方进行实验，证明其对大小鼠急性酒精性肝损伤的保护作用显著，降低血清ALT、AST及肝组织ALT水平，改善组织病理状态，促进肝细胞损伤恢复，实验也证明了其可以通过清除自由基、抗脂质过氧化而起到保肝作用。
本发明一种保健食品的组合物所述的菊花，为菊科植物菊的干燥头状花序，性味甘苦寒，具有散风清热、平肝明目之功，始载于《神农本草经》，列为上品，记载其可“久服利血气、轻身、延年”，素有“药膳佳肴、饮中极品”之美誉。《纲目拾遗》：“专入阳分，主诸风头眩，解酒毒疔肿”，王好古说其“主肝气不足”。现代医学分析表明，菊花含有挥发油、腺嘌呤、胆碱、水苏碱、菊甙、氯原酸、氨基酸、黄酮类及多种微量元素，有抗菌、抗病毒、解毒的作用，还能增强毛细血管抵抗力，抑制毛细血管的通透性而有抗炎作用。
本发明一种保健食品的组合物所述的茯苓，为多孔菌科真菌茯苓的干燥菌核，性味甘淡平，具有利水渗湿，健脾宁心之功效，是传统的名贵中药材，据《本草纲目》记载久服茯苓可以“除百病，润肌肤，益寿延年”，被誉为“仙药之上品”，中药“八珍”之一。现代研究表明茯苓主要含茯苓多糖、茯苓酸等有效成分，功能试验证明茯苓对四氯化碳所致大鼠肝损伤有明显保护作用，能显著降低转氨酶活性，防止肝细胞坏死，也有实验证明茯苓对半乳糖胺引起的急性肝功能衰竭具有明显预防作用，可改善血浆氨基酸失衡。同时，茯苓还可增强免疫力，提高机体抗病能力。
本发明一种保健食品的组合物所述的橘皮，为芸香科植物橘及其载培变种的干燥成熟果皮，因以陈年者辛辣之气稍有不甚烈为佳，故称陈皮。橘皮性味辛温，有理气健脾、燥湿化痰之功效。《本草纲目》谓其能“疗酒病”，《圣济总录》载“用橘皮汤可治疗饮酒过度”。成分研究认为橘皮主要含挥发油、黄酮甙、橙皮甙等，有实验研究证明以橘皮等组成的合剂可显著降低急性酒精中毒小鼠血液中乙醇浓度，明显减少急性酒精中毒小鼠的自主活动、对抗酒精的兴奋作用。药理研究证明橘皮甙还有抗炎、抗溃疡、利胆的作用。
本发明一种保健食品的组合物所述的牛磺酸，化学名为2-氨基乙磺酸，是名贵药材牛磺的主要功效成分，现多为人工合成，是细胞内含量最丰富的含磺酸基的β自由氨基酸，是人体必不可少的一种营养成分，在体内分布广泛，是通过体内的半胱氨酸转化而来。肝脏是合成牛磺酸的主要场所，也是牛磺酸的重要靶器官，但是人体合成牛磺酸的能力较弱，肝病时尤甚，而满足不了人体多方面的需求，故需要从体外摄入来补充牛磺酸。近代研究证明，牛磺酸具有维持组织渗透压、稳定细胞膜、调节细胞内钙平衡、抗脂质过氧化、促进脂肪代谢、保护细胞、增强免疫力等广泛的生物学功能。大量的医学研究证实牛磺酸对肝损伤有明显的保护作用，能够有效地保护酒精对大鼠肝脏的损伤。动物实验也证明，牛磺酸能清除氧自由基，对肝组织具有直接抗氧化损伤作用，抗肝脏脂肪变性和脂质过氧化、抗肝纤维化的作用，组织病理研究也证实了牛磺酸能改善硫代乙酰胺(TAA)引起的肝脏坏死，抑制肝细胞凋亡，起到对脂肪肝的保护作用。枳椇子、葛根、青果、菊花、茯苓、橘皮、牛磺酸因其独特的功效，再经科学的配方，先进的生产工艺，使得其功效成分充分提取并保留，试验证明，具有对化学性肝损伤有辅助保护的保健功能。
实施例1：一种保健食品，它是指一种具有解酒防醉护肝的含片保健食品，是由以下原料按重量份数组成枳椇子50份、葛根30份、青果20份、菊花20份、茯苓20份、橘皮10份、牛磺酸3份、白砂糖750份、麦芽糖饴260份、麦芽糊精20份、薄荷脑3份、桉叶油0.5份；取枳椇子、葛根、青果、菊花、茯苓、橘皮置提取锅中加水适量加热煮沸提取三次即得药汁，药汁浓缩成含水约40％得稠膏，加入牛磺酸混合均匀得药膏备用；然后将白砂糖、麦芽糖饴、麦芽糊精置熬糖锅中加适量水边加热边搅拌熬煮至温度达145℃，停止加热，加入药膏，抽真空至真空度达0.08MPa即得糖膏，将糖膏出锅置于冷却台上加入薄荷脑、桉叶油混合均匀即得混合糖膏，压片、包装即得产品。
实施例2：一种保健食品，它是指一种具有解酒防醉护肝的含片保健食品，是由以下原料按重量份数组成枳椇子60份、葛根40份、青果30份、菊花30份、茯苓30份、橘皮15份、牛磺酸5份、白砂糖750份、麦芽糖饴260份、麦芽糊精20份、薄荷脑5份、桉叶油0.5份；取枳椇子、葛根、青果、菊花、茯苓、橘皮置提取锅中加水适量加热煮沸提取三次即得药汁，药汁浓缩成含水约40％得稠膏，加入牛磺酸混合均匀得药膏备用；然后将白砂糖、麦芽糖饴、麦芽糊精置熬糖锅中加适量水边加热边搅拌熬煮至温度达145℃，停止加热，加入药膏，抽真空至真空度达0.08MPa即得糖膏，将糖膏出锅置于冷却台上加入薄荷脑、桉叶油混合均匀即得混合糖膏，压片、包装即得产品。
Claims (1)
1.一种保健食品的组合物，其特征在于，它是由以下原料和重量份数组成：枳椇子50-60份、葛根30-40份、青果20-30份、菊花20-30份、茯苓20-30份、橘皮10-15份、牛磺酸3-5份、白砂糖750份、麦芽糖饴260份、麦芽糊精20份、薄荷脑3-5份、桉叶油0.5份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210287811.5A CN103584077B (zh) | 2012-08-14 | 2012-08-14 | 一种保健食品的组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210287811.5A CN103584077B (zh) | 2012-08-14 | 2012-08-14 | 一种保健食品的组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103584077A true CN103584077A (zh) | 2014-02-19 |
| CN103584077B CN103584077B (zh) | 2015-08-19 |
Family
ID=50074561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210287811.5A Active CN103584077B (zh) | 2012-08-14 | 2012-08-14 | 一种保健食品的组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103584077B (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104473094A (zh) * | 2014-12-29 | 2015-04-01 | 楚雄智峰科技有限公司 | 一种具有天然变味及解酒保健作用的含片及其制备方法 |
| CN104666931A (zh) * | 2015-02-02 | 2015-06-03 | 广西中医药大学 | 具有护肝解酒作用的组合物及其应用 |
| CN111713590A (zh) * | 2020-06-01 | 2020-09-29 | 邱晓东 | 一种助解酒奶糖 |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1371732A (zh) * | 2002-02-28 | 2002-10-02 | 傅强 | 一种解酒饮料 |
| CN1887337A (zh) * | 2005-06-28 | 2007-01-03 | 吴笛 | 葛花醒酒咀嚼片及其制备方法 |
| CN101455354A (zh) * | 2007-12-14 | 2009-06-17 | 中国科学院微生物研究所 | 天然菌草保肝解酒剂 |
| CN101461526A (zh) * | 2008-11-27 | 2009-06-24 | 成都润馨堂药业有限公司 | 具有保肝解酒作用的保健品及其制备方法 |
| CN101632830A (zh) * | 2009-08-07 | 2010-01-27 | 赵夫 | 醒酒口服液 |
| CN101745042A (zh) * | 2008-12-12 | 2010-06-23 | 北京宝德润生医药科技发展有限公司 | 一种具有解酒保肝作用的组合物及其制备方法 |
| CN101919463A (zh) * | 2010-09-10 | 2010-12-22 | 纪顺良 | 一种解酒茶及其制备方法 |
| CN101990963A (zh) * | 2009-08-20 | 2011-03-30 | 安徽奥来新能源有限公司 | 养生解酒茶 |
| CN102335251A (zh) * | 2011-10-12 | 2012-02-01 | 扬州大学 | 一种具有解酒功能的组合物及其制备方法 |
| CN102416138A (zh) * | 2012-01-10 | 2012-04-18 | 袁霞 | 一种具有解酒降脂养胃作用的组合物及其制备方法 |
-
2012
- 2012-08-14 CN CN201210287811.5A patent/CN103584077B/zh active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1371732A (zh) * | 2002-02-28 | 2002-10-02 | 傅强 | 一种解酒饮料 |
| CN1887337A (zh) * | 2005-06-28 | 2007-01-03 | 吴笛 | 葛花醒酒咀嚼片及其制备方法 |
| CN101455354A (zh) * | 2007-12-14 | 2009-06-17 | 中国科学院微生物研究所 | 天然菌草保肝解酒剂 |
| CN101461526A (zh) * | 2008-11-27 | 2009-06-24 | 成都润馨堂药业有限公司 | 具有保肝解酒作用的保健品及其制备方法 |
| CN101745042A (zh) * | 2008-12-12 | 2010-06-23 | 北京宝德润生医药科技发展有限公司 | 一种具有解酒保肝作用的组合物及其制备方法 |
| CN101632830A (zh) * | 2009-08-07 | 2010-01-27 | 赵夫 | 醒酒口服液 |
| CN101990963A (zh) * | 2009-08-20 | 2011-03-30 | 安徽奥来新能源有限公司 | 养生解酒茶 |
| CN101919463A (zh) * | 2010-09-10 | 2010-12-22 | 纪顺良 | 一种解酒茶及其制备方法 |
| CN102335251A (zh) * | 2011-10-12 | 2012-02-01 | 扬州大学 | 一种具有解酒功能的组合物及其制备方法 |
| CN102416138A (zh) * | 2012-01-10 | 2012-04-18 | 袁霞 | 一种具有解酒降脂养胃作用的组合物及其制备方法 |
Non-Patent Citations (4)
| Title |
|---|
| ZHENBOBO: "可以嚼着吃的解酒食品——华北牌葛花茯苓片", 《新浪博客》 * |
| 宋歌等: "古代解酒方用药统计分析", 《时珍国医国药》 * |
| 李俊: "解酒10法", 《农村新技术》 * |
| 苗明三，刘利军，尚炽昌: "醒酒冲剂药效学研究", 《河南中医药学刊》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104473094A (zh) * | 2014-12-29 | 2015-04-01 | 楚雄智峰科技有限公司 | 一种具有天然变味及解酒保健作用的含片及其制备方法 |
| CN104666931A (zh) * | 2015-02-02 | 2015-06-03 | 广西中医药大学 | 具有护肝解酒作用的组合物及其应用 |
| CN104666931B (zh) * | 2015-02-02 | 2018-03-09 | 广西中医药大学 | 具有护肝解酒作用的组合物及其应用 |
| CN111713590A (zh) * | 2020-06-01 | 2020-09-29 | 邱晓东 | 一种助解酒奶糖 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103584077B (zh) | 2015-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20070111623A (ko) | 한약재 추출물을 유효성분으로 함유하는 관상동맥성 심장 질환 또는 동맥경화증의 예방 또는 치료용 약학 조성물 | |
| CN101269153A (zh) | 一种解酒组合物及其制备方法 | |
| KR20020022342A (ko) | 스트레스 예방 및 치료를 위한 항스트레스제 조성물 | |
| CN103005556B (zh) | 一种饮料 | |
| KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
| CN109601795A (zh) | 以赶黄草为主要原料的组合物解酒饮料及其制备方法 | |
| CN103251698B (zh) | 一种具有解酒保肝护胃功效的葛根饮液及其制法 | |
| CN103053765B (zh) | 一种解酒消食保肝袋泡茶的制备方法 | |
| CN108813501B (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
| CN103584077B (zh) | 一种保健食品的组合物 | |
| CN103749839A (zh) | 一种灵芝万寿果茶 | |
| CN106418073A (zh) | 一种天然竹香饮料及其加工方法 | |
| CN105902857A (zh) | 一种黄芪玉米须枸杞子降血糖口服液及其制备方法 | |
| CN105733902A (zh) | 一种解酒型柳叶蜡梅葛根黄酒的制备方法 | |
| CN105767330A (zh) | 一种保健茶 | |
| CN108925807A (zh) | 一种降糖降压的固体饮料及其制备方法 | |
| KR20140146378A (ko) | 생약혼합물을 유효성분으로 함유하는 피로회복용 조성물 | |
| CN103704409B (zh) | 一种凉茶及其制备方法 | |
| CN102524869A (zh) | 红枣秋梨枸杞浓浆 | |
| CN102524868A (zh) | 红枣秋梨枇杷浓浆 | |
| KR101381277B1 (ko) | 홍삼을 함유하는 고장초 겔 | |
| CN111888431A (zh) | 一种治疗糖尿病的组合物及其制备方法 | |
| CN103798877A (zh) | 一种保健饮料的组合物 | |
| CN104474406A (zh) | 滋阴润肺养生中药酒及制备方法 | |
| CN104352836A (zh) | 一种含黄蜀葵植物提取物的复方减肥泡腾片 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Huang Weian Inventor after: Meng Yi Inventor after: Teng Guang Inventor after: Li Jianqiang Inventor after: Wei Xiaoming Inventor after: Chen Lei Inventor before: Huang Weian Inventor before: Li Jianqiang Inventor before: Wei Xiaoming Inventor before: Chen Lei |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG WEIAN LI JIANQIANG WEI XIAOMING CHEN LEI TO: HUANG WEIAN MENG YI TENG GUANG LI JIANQIANG WEI XIAOMING CHEN LEI |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 537001 Yuyao Group Production Base, Renhou Town, Yuzhou District, Yulin City, Guangxi Zhuang Autonomous Region Patentee after: Guangxi Yulin Juan Health Products Co.,Ltd. Address before: 537001 Yuyao Group Production Base, Renhou Town, Yuzhou District, Yulin City, Guangxi Zhuang Autonomous Region Patentee before: GUANGXI YULIN PHARMACEUTICAL GROUP JUAN HEALTH-CARE PRODUCTS CO.,LTD. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20230412 Address after: Room 308, Building 4, No. 74, Xiashe, Binglun Village, Hushi Town, Xiuyu District, Putian City, Fujian Province, 351100 Patentee after: Fujian Lishizhen Health Products Group Co.,Ltd. Address before: 537001 Yuyao Group Production Base, Renhou Town, Yuzhou District, Yulin City, Guangxi Zhuang Autonomous Region Patentee before: Guangxi Yulin Juan Health Products Co.,Ltd. |
|
| TR01 | Transfer of patent right |